Hence, the contributions of STAT5 activation in HCC share certain similarities with breast cancer—STAT5 can act both as a tumour suppressor, in conditions where STAT3 is active in tumorigenesis, or as an oncogene to drive tumour aggressiveness in other instances. This evidence concerns the gene STAT5A and hepatocellular carcinoma.